Evidence map›Paper›PMID 24270545›Full record

ArticleNature medicine2013

CD28 and ITK signals regulate autoreactive T cell trafficking.

Nitya Jain, Bing Miu, Jian-kang Jiang, Kai K McKinstry, Amanda Prince, Susan L Swain, Dale L Greiner, Craig J Thomas, Michael J Sanderson, Leslie J Berg and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Balancing immune activation with Itk.Trends in pharmacological sciences · 2024
    Article
  3. CD8ImmunoHorizons · 2020
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Article
  13. Quantitative analysis of B-lymphocyte migration directed by CXCL13.Integrative biology : quantitative biosciences from nano to macro · 2016
    Article
  14. Article
  15. Article
  16. Review
  17. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Nitya JainDepartment of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Bing Miu
Jian-kang Jiang
Kai K McKinstry
Amanda Prince
Susan L Swain
Dale L Greiner
Craig J Thomas
Michael J Sanderson
Leslie J Berg
Joonsoo Kang
University of Massachusetts Chan Medical School · USID Genomics (United States) · USNational Institutes of Health · US

Funding

Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2M
T cell memory to TB in the lungP01AI046530 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 1999 to 2013
$22.2M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
ITK: an emerging target for treatment of T cell-mediated autoimmune diseaseR01AI083505 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BERG, LESLIE JOAN, KANG, JOONSOO · 2011 to 2015
$2.8M
Production of animal models to define how CTLA-4 impacts to T1D susceptibilityRC1DK086474 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KANG, JOONSOO · 2009 to 2010
$976k
Intramural NIH HHSNIAID NIH HHS AI046530NIAID NIH HHS AI050864NIAID NIH HHS AI083505NIAID NIH HHS AI46629NIAID NIH HHS P01 AI046530NIAID NIH HHS P01 AI046629NIAID NIH HHS R01 AI083505NIAID NIH HHS U19 AI050864NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIDDK NIH HHS RC1 DK086474
6 · The paper itself

Abstract

Activation of self-reactive T cells and their trafficking to target tissues leads to autoimmune organ destruction. Mice lacking the co-inhibitory receptor cytotoxic T lymphocyte antigen-4 (CTLA-4) develop fatal autoimmunity characterized by lymphocytic infiltration into nonlymphoid tissues. Here, we demonstrate that the CD28 co-stimulatory pathway regulates the trafficking of self-reactive Ctla4(-/-) T cells to tissues. Concurrent ablation of the CD28-activated Tec family kinase ITK does not block spontaneous T cell activation but instead causes self-reactive Ctla4(-/-) T cells to accumulate in secondary lymphoid organs. Despite excessive spontaneous T cell activation and proliferation in lymphoid organs, Itk(-/-); Ctla4(-/-) mice are otherwise healthy, mount antiviral immune responses and exhibit a long lifespan. We propose that ITK specifically licenses autoreactive T cells to enter tissues to mount destructive immune responses. Notably, ITK inhibitors mimic the null mutant phenotype and also prevent pancreatic islet infiltration by diabetogenic T cells in mouse models of type 1 diabetes, highlighting their potential utility for the treatment of human autoimmune disorders.

Indexed as

AnimalsCD28 AntigensCells, CulturedChemotaxis, LeukocyteCHO CellsCricetinaeCricetulusCTLA-4 AntigenFemaleHomeostasisMaleMiceMice, Inbred C57BLMice, Inbred NODMice, KnockoutMice, SCIDCD28 AntigensCTLA-4 Antigenemt protein-tyrosine kinaseProtein-Tyrosine Kinases

Identifiers

PMID24270545
PMCPMC4005518
OpenAlexW1977635151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.